What is B. Riley's Forecast for KindlyMD Q3 Earnings?

Key Points

• B. Riley has projected that KindlyMD will report earnings of **($0.01)** per share for Q3 2025, while maintaining a **"Buy"** rating with a target price of **$2.00**.
• KindlyMD's most recent earnings report for August 5th showed a loss of **($0.34)** EPS and revenue of **$0.41 million**, indicating significant financial challenges with a negative return on equity and net margin.
• Two analysts have issued a **Buy** rating and one a **Sell** rating for KindlyMD, with an average rating of **"Hold"** and a market price target of **$5.00** based on recent evaluations.

KindlyMD, Inc. (NASDAQ:NAKA - Free Report) - Equities research analysts at B. Riley issued their Q3 2025 earnings per share (EPS) estimates for KindlyMD in a research report issued to clients and investors on Wednesday, October 15th. B. Riley analyst F. Shabalin forecasts that the company will earn ($0.01) per share for the quarter. B. Riley currently has a "Buy" rating and a $2.00 target price on the stock. B. Riley also issued estimates for KindlyMD's Q4 2025 earnings at $0.00 EPS, FY2025 earnings at ($0.53) EPS and FY2026 earnings at ($0.01) EPS.

KindlyMD (NASDAQ:NAKA - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported ($0.34) EPS for the quarter. The firm had revenue of $0.41 million during the quarter. KindlyMD had a negative return on equity of 131.09% and a negative net margin of 244.00%.

Several other equities research analysts have also recently weighed in on NAKA. Wall Street Zen upgraded KindlyMD to a "sell" rating in a report on Saturday. Weiss Ratings reiterated a "sell (d-)" rating on shares of KindlyMD in a report on Wednesday, October 8th. Finally, Maxim Group assumed coverage on shares of KindlyMD in a report on Wednesday, September 3rd. They issued a "buy" rating and a $8.00 price objective for the company. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $5.00.

KindlyMD Trading Down 4.9%

Shares of NASDAQ:NAKA opened at $0.72 on Monday. The company has a market capitalization of $297.79 million, a P/E ratio of -0.84 and a beta of 31.10. KindlyMD has a 12 month low of $0.65 and a 12 month high of $34.77. The company's 50-day moving average price is $4.58.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.